Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies

Candida Vitale, Lorenzo Falchi, Maria Ciccone, Jan Burger, Naveen Pemmaraju, Gautam Borthakur, William G. Wierda, Michael J. Keating, Alessandra Ferrajoli

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences